Cargando…

The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy

The NOD-like receptor protein 3 (NLRP3) inflammasome is a multi-protein signalling complex integral to the chronic inflammatory response, activated in response to sterile and non-sterile cellular damage. The assembly and activation of the NLRP3 inflammasome comprise a two-step process involving nucl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, B. M., Cliff, C. L., Lee, K., Squires, P. E., Hills, C. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218738/ https://www.ncbi.nlm.nih.gov/pubmed/35755447 http://dx.doi.org/10.3389/fphys.2022.907504

Ejemplares similares

Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury
por: Roger, Elena, et al.
Publicado: (2023)

DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy
por: Yang, Ming, et al.
Publicado: (2021)

Blocking connexin 43 hemichannel‐mediated ATP release reduces communication within and between tubular epithelial cells and medullary fibroblasts in a model of diabetic nephropathy
por: Williams, Bethany M., et al.
Publicado: (2022)

The CXCL1-CXCR2 Axis Mediates Tubular Injury in Diabetic Nephropathy Through the Regulation of the Inflammatory Response
por: Tang, Hanfen, et al.
Publicado: (2021)

NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
por: Luo, Beibei, et al.
Publicado: (2017)

The NLRP3 Inflammasome: Role and Therapeutic Potential in Pain Treatment
por: Starobova, Hana, et al.
Publicado: (2020)

Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome
por: Wang, Shaofei, et al.
Publicado: (2019)

Activation of the NLRC4 inflammasome in renal tubular epithelial cell injury in diabetic nephropathy
por: Wang, Yulin, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome in IgA Nephropathy
por: Wu, Xiaofang, et al.
Publicado: (2022)

Inflammation and oxidative stress in salt sensitive hypertension; The role of the NLRP3 inflammasome
por: Ertuglu, Lale A., et al.
Publicado: (2022)

Calcium-sensing receptor-mediated NLRP3 inflammasome activation in rheumatoid arthritis and autoinflammation
por: Werner, Lina Emilia, et al.
Publicado: (2023)

Inflammation triggered by the NLRP3 inflammasome is a critical driver of diabetic bladder dysfunction
por: Hughes, Francis M., et al.
Publicado: (2022)

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
por: Sharma, Arpeeta, et al.
Publicado: (2018)

Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
por: Dong, Wenmin, et al.
Publicado: (2022)

Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition
por: Nielsen, Stine E., et al.
Publicado: (2009)

Thickness of glomerular and tubular basement membranes in preclinical and clinical stages of diabetic nephropathy
por: Tyagi, I., et al.
Publicado: (2008)

Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2021)

Mitochondrial DNA Promotes NLRP3 Inflammasome Activation and Contributes to Endothelial Dysfunction and Inflammation in Type 1 Diabetes
por: Pereira, Camila A., et al.
Publicado: (2020)

Effects of Shizhifang on NLRP3 Inflammasome Activation and Renal Tubular Injury in Hyperuricemic Rats
por: Wu, Yansheng, et al.
Publicado: (2017)

Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling
por: Lu, Miaomiao, et al.
Publicado: (2017)

Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications
por: López-Novoa, José M, et al.
Publicado: (2011)

Assessment of Glomerular and Tubular Function in the Evaluation of Diabetic Nephropathy: A Cross-sectional Study
por: Agarwal, Sandeep Kumar, et al.
Publicado: (2018)

Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat
por: Xie, Yebin, et al.
Publicado: (2020)

Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis
por: Han, Yachun, et al.
Publicado: (2018)

Aerobic exercise alleviates pyroptosis-related diseases by regulating NLRP3 inflammasome
por: Hu, Shujuan, et al.
Publicado: (2022)

Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc(–/–) and Nlrp3(–/–) Mice
por: Chen, Yu, et al.
Publicado: (2019)

Urinary Markers of Glomerular Injury in Diabetic Nephropathy
por: Cohen-Bucay, Abraham, et al.
Publicado: (2012)

Roles of DNA damage in renal tubular epithelial cells injury
por: Wang, Peipei, et al.
Publicado: (2023)

Sweet Taste Receptors Mediated ROS-NLRP3 Inflammasome Signaling Activation: Implications for Diabetic Nephropathy
por: Zhou, Luping, et al.
Publicado: (2018)

Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene
por: Boini, Krishna M., et al.
Publicado: (2016)

Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome
por: Li, Xueling, et al.
Publicado: (2019)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
por: Wang, Shaofei, et al.
Publicado: (2017)

Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury
por: Ding, Wei, et al.
Publicado: (2016)

Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome-mediated inflammation
por: Feng, Hui, et al.
Publicado: (2021)

Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
por: Shahzad, Khurrum, et al.
Publicado: (2015)

Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus
por: Wang, Yao, et al.
Publicado: (2017)

Urinary Markers of Tubular Injury in Early Diabetic Nephropathy
por: Fiseha, Temesgen, et al.
Publicado: (2016)

NLRP3-mediated pyroptosis in diabetic nephropathy
por: Wan, Jiayi, et al.
Publicado: (2022)

Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury
por: Kim, Su-Mi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fh2ql0k4ru70jr43viuc4g77fp